Literature DB >> 12776308

Meeting the challenges of the new K/DOQI guidelines.

Garabed Eknoyan1.   

Abstract

Substantial gains in the dialytic treatment of patients with end-stage renal disease have been made during the past several decades. However, inadequate attention has been given to the problem of chronic kidney disease (CKD) as a whole. CKD and its associated complications emerge years before patients develop kidney failure and become dialysis dependent. It now is evident that to improve dialysis outcomes, it is essential for practitioners to recognize the earlier stages of CKD, not only to retard disease progression, but also to prevent and treat its complications and comorbidities long before the need for dialysis arises. The recently published National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines identify the broad-based problem of CKD in the general population and introduce action plans that can be used at the different stages of CKD. This article discusses the process behind the development of the CKD guidelines and highlights the disease evaluation, classification, and stratification system provided by the guidelines. It is hoped that widespread implementation of these recommendations will increase the understanding of CKD among both providers and patients and eliminate many of the obstacles that nephrologists have faced in providing optimal care to dialysis patients in particular and to patients with CKD in general.

Entities:  

Mesh:

Year:  2003        PMID: 12776308     DOI: 10.1016/s0272-6386(03)00371-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy.

Authors:  Kara L Watts; Abhishek Srivastava; Wilson Lin; Daniel Schoenfeld; Matthew Abramowitz; Joshua M Stern
Journal:  Urolithiasis       Date:  2019-02-12       Impact factor: 3.436

2.  Implementation of a CKD checklist for primary care providers.

Authors:  Mallika L Mendu; Louise I Schneider; Ayal A Aizer; Karandeep Singh; David E Leaf; Thomas H Lee; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-18       Impact factor: 8.237

3.  Interventional study to improve adherence to phosphate binder treatment in dialysis patients.

Authors:  Bodil Jahren Hjemås; Katrine Bøvre; Liv Mathiesen; Jonas Christoffer Lindstrøm; Kathrin Bjerknes
Journal:  BMC Nephrol       Date:  2019-05-17       Impact factor: 2.388

4.  Effects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease.

Authors:  Huiling Huang; Chunmei Zeng; Yuedong Ma; Yili Chen; Cong Chen; Chen Liu; Yugang Dong
Journal:  Dis Markers       Date:  2015-10-08       Impact factor: 3.434

5.  Efficacy and safety of evocalcet in treatment of secondary hyperparathyroidism in chronic kidney disease on hemodialysis patients: A protocol for a systematic review and meta-analysis.

Authors:  Jing Xie; Xueying Li; Yang Chen; Ming Chen; Nan Mao; Junming Fan
Journal:  Medicine (Baltimore)       Date:  2020-11-13       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.